OctoPlus N.V. (Euronext: OCTO) is a biopharmaceutical company creating improved pharmaceutical products that are based on OctoPlus' drug delivery technologies and have fewer side effects, improved patient convenience and a better tolerability than existing products. The Company currently has 4 products in preclinical and clinical development. In addition, OctoPlus is a leading provider of drug formulation and clinical scale manufacturing services, with a focus on difficult to formulate active pharmaceutical ingredients in injectable formulations. For more information about OctoPlus, please visit our website http://www.octoplus.nl
Nobilon International BV, part of Organon, a biopharmaceutical business unit of Akzo Nobel, was founded in 2003. It has production and R&D facilities in Boxmeer and Oss, the Netherlands. The biotechnology company is dedicated to develop, produce and market human vaccines against infectious diseases, building on existing expertise within sister companies Intervet and Organon. Nobilon focuses on respiratory and traveller's diseases. One of its core expertises is large scale cell culture production of viruses, including influenza. Nobilon currently employs approximately 75 staff in production and R&D. http://www.nobilon.com
About Solvay Pharmaceuticals
Solvay Pharmaceuticals is a research driven group of companies that
constitute the global p
|SOURCE Top Institute Pharma|
Copyright©2007 PR Newswire.
All rights reserved